ID: ALA4861278

Max Phase: Preclinical

Molecular Formula: C19H14F4N6O2

Molecular Weight: 434.35

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@](O)(Cn1cc(-c2ccc(F)cc2)nn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C19H14F4N6O2/c1-18(31,10-29-9-16(27-28-29)11-2-4-12(20)5-3-11)17(30)26-13-6-14(19(21,22)23)15(7-24)25-8-13/h2-6,8-9,31H,10H2,1H3,(H,26,30)/t18-/m0/s1

Standard InChI Key:  DHLFALGEKMYIFT-SFHVURJKSA-N

Associated Targets(Human)

Androgen Receptor 11781 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Androgen Receptor 5522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 434.35Molecular Weight (Monoisotopic): 434.1114AlogP: 2.76#Rotatable Bonds: 5
Polar Surface Area: 116.72Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.00CX Basic pKa: 0.56CX LogP: 2.97CX LogD: 2.97
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.60Np Likeness Score: -1.75

References

1. He Y, Hwang DJ, Ponnusamy S, Thiyagarajan T, Mohler ML, Narayanan R, Miller DD..  (2021)  Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.,  64  (15.0): [PMID:34269581] [10.1021/acs.jmedchem.1c00439]

Source